FFWM vs JPM
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
FFWM exhibits severe financial distress, highlighted by a critical Piotroski F-Score of 1/9, indicating a near-total collapse in fundamental health. While the stock trades at a significant discount to book value (P/B 0.59), this is offset by a devastating profit margin of -91.02% and a consistent pattern of massive earnings misses over the last four quarters. Despite a positive YoY revenue growth of 24.60%, the operational efficiency is non-existent, and the technical trend is purely bearish. The valuation appeal is a 'value trap' given the current trajectory of negative ROE and ROA.
JPM exhibits a concerning Piotroski F-Score of 2/9, indicating weak short-term fundamental health, and currently trades at a significant premium to both its Graham Number ($239.11) and Intrinsic Value ($140.07). While the company maintains a strong ROE of 16.13% and dominant market positioning, negative YoY earnings growth (-3.60%) and bearish insider activity from the CEO and CFO signal internal caution. The stock's current price of $313.68 suggests the market is pricing in a growth premium that is not currently supported by the deterministic health or value metrics.
Compare Another Pair
Related Comparisons
FFWM vs JPM: Head-to-Head Comparison
This page compares First Foundation Inc. (FFWM) and JPMorgan Chase & Co. (JPM) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.